Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors.

Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Abstract Text:

    y chenY Chen,k d k lukK D K Luk,k m c cheungK M C Cheung,r xuR Xu,m c linM C Lin,w w luW W Lu,j c y leongJ C Y Leong,h-f kungH-F Kung,

    Previous reports have suggested that bone morphogenetic protein (BMP) gene therapy could be applied for in vivo bone regeneration. However, these studies were conducted either using immunodeficient animals because of immunogenicity of adenovirus vectors, or using ex vivo gene transfer technique, which is much more difficult to handle. Adeno-associated virus (AAV) is a replication-defective virus without any association with immunogenicity and human disease. This study was conducted to investigate whether orthotopic new bone formation could be induced by in vivo gene therapy using AAV-based BMP2 vectors. To test the feasibility of this approach, we constructed an AAV vector carrying human BMP2 gene. Mouse myoblast cells (C2C12) transduced with this vector could produce and secrete biologically active BMP2 protein and induce osteogenic activity, which was confirmed by ELISA and alkaline phosphatase activity assay. For in vivo study, AAV-BMP2 vectors were directly injected into the hindlimb muscle of immunocompetent Sprague-Dawley rats. Significant new bone under X-ray films could be detected as early as 3 weeks postinjection. The ossification tissue was further examined by histological and immunohistochemical analysis. This study is, to our knowledge, the first to establish the feasibility of AAV-based BMP2 gene therapy for endochondral ossification in immunocompetent animals.

    Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Publishing Authors By Initials

    y chenY Chen,kd lukKD Luk,km cheungKM Cheung,r xuR Xu,mc linMC Lin,ww luWW Lu,jc leongJC Leong,hf kungHF Kung,

    For similar peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research

    PUBMED ID PMID:

    MEDLINE DATE:

    Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Gene therapy

    VOLUME: 10

    Page Numbers: 1345-53

    Journal Abbreviation: Gene Ther.

    ISSN: 0969-7128

    DAY: 19

    MONTH: Aug

    YEAR: 2003

    Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9421525

    Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Keywords Mesh Terms:

    KEYWORDS: Transforming Growth Factor beta

    MESH TERMS: methods

    Chemical & Substance for Abstract: Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Information

    Substance Name: bone morphogenetic protein 2

    Registry Number: 0

    Grant and Affiliation Information for Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors.

    AFFILIATION: Department of Orthopaedic Surgery, Faculty of Medicine, The University of Hong Kong, Hong Kong.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Gene Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News